Konstantinos Tsioufis

Konstantinos Tsioufis

Interventional cardiologist / Cardiologist
First Cardiology Clinic, University of Athens, Hippokration Hospital - Athens, Greece

Latest contributions

New frontier in renal denervation: data, devices and developments

22 May 2025 – From EuroPCR 2025

Advance your understanding of renal denervation with the latest data, innovative devices, and emerging developments. This session reviews the 12-month results of the REDUCED 1 trial evaluating the TIVUS system, explores safety and efficacy of novel renal stimulation techniques, and presents outcomes from registries including patients...

New frontier in renal denervation: data, devices and developments

Hypertension interventions in specific scenarios

22 May 2025 – From EuroPCR 2025

Explore interventions for hypertension in specific patient populations, including renal artery stenosis treatment and the role of renal denervation. Discuss multidisciplinary approaches and evidence supporting renal denervation in advanced kidney disease, heart failure, and young patients.

Hypertension interventions in specific scenarios

Novelties and future developments of sympathetic denervation to control blood pressure

21 May 2025 – From EuroPCR 2025

Discover the latest novelties and future directions in sympathetic denervation for blood pressure control. This session presents preclinical safety data, lesion characteristics, anatomic guidance innovations, multi-organ denervation pilot studies, and breakthrough technologies like the Electroducer sleeve to enhance renal denervation interventions.

Novelties and future developments of sympathetic denervation to control blood pressure

More on long-term responsiveness and effectiveness of renal denervation

21 May 2025 – From EuroPCR 2025

This session presents comprehensive data on the long-term responsiveness and effectiveness of renal denervation. Topics include outcomes in patients with chronic kidney disease, arterial stiffness correlations, safety profiles over nine years, and economic evaluations across European healthcare systems.

More on long-term responsiveness and effectiveness of renal denervation

Getting started with a renal denervation programme

20 May 2025 – From EuroPCR 2025

Begin your renal denervation program with this comprehensive session focusing on the importance of a multidisciplinary hypertension team, procedural techniques with current devices, and expected clinical outcomes across patient subgroups. Practical case examples illustrate effective team-based hypertension management and procedural execution.

Getting started with a renal denervation programme

PCRonline @ ESC Congress 2024: the interventional cardiology perspective!

26 Jul 2024

What was new and hot in interventional cardiology at #ESCCongress 2024!

Clinical adoption of renal denervation: no more excuses

15 May 2024 – From EuroPCR 2024

Clinical adoption of renal denervation: no more excuses

Renal denervation step by step: how to perform a safe and effective procedure

14 May 2024 – From EuroPCR 2024

This session provides a comprehensive overview of renal denervation, covering the essential aspects of patient selection, preprocedural assessment and imaging, the technical steps for performing safe and effective radiofrequency and ultrasound-based renal denervation, and the importance of post-procedural follow-up. The discussions aim to equip the audience...

Renal denervation step by step: how to perform a safe and effective procedure

Renal denervation for treatment of hypertension – heading for new shore

19 Jul 2022

View this replay of a LIVE Round Table Webinar - Renal denervation for treatment of hypertension - with F. Mahfoud, A. Pathak, K. Tsioufis and T. Zellera

Interventions for hypertension and heart failure

19 May 2022 – From EuroPCR 2022

View slides and videos on procedures for hypertension and heart failure including observations and outcomes from the RELIEVE-HF roll-in cohort, a novel approach for performing renal denervation, RDN registry of a resistant hypertension multidisciplinary team..

Interventions for hypertension and heart failure

EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!

17 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in hypertension management! Blood pressure and MACE reductions after renal denervation: 3-year GSR results, patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio, and SPYRAL-HTN ON MED 3 year data.

EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!

How does Paradise renal denervation fit into hypertension treatment management?

20 May 2021 – From EuroPCR 2021

Watch this session presented by Felix Mahfoud, Philipp Lurz, Konstantinos Tsioufis and Joachim Weil in order to understand the ultrasound-based renal denervation procedure and summary of the latest clinical data, to review consensus statements and guidelines for the renal denervation therapy today, and to hear expert perspectives on how to establish...

How does Paradise renal denervation fit into hypertension treatment management?

Treatment of uncontrolled hypertension: case-based discussion

19 May 2021 – From EuroPCR 2021

Watch this session if you want to share indications and optimal criteria for patient selection.

This session was originally presented during EuroPCR 2021.

Treatment of uncontrolled hypertension: case-based discussion

Treating hypertension in 2020: A pivotal moment for renal denervation

Watch this video if you want to revisit the clinical evidence behind the Medtronic renal denervation programme and to hear the new Pivotal OFF MED result.

Speakers: Konstantinos Tsioufis, Michael Böhm

This interview supported by Medtronic was filmed at PCR e-Course 2020 : see more videos here…

A pivotal moment for renal denervation

The resurgence of renal denervation

25 Jun 2020 – From PCR e-Course

Following the latest trial results showing the safety and efficacy of renal denervation to treat hypertension, this session will provide you with a high-level update on where we stand currently and where we are moving in the near future.

This session was originally presented during PCR e-Course...

The resurgence of renal denervation

Truths and myths about renal denervation

A session at EuroPCR 2019 was dedicated to the truths and myths surrounding renal denervation. Does ablation location matter? Is safe and successful denervation as simple as measuring ablation depth? Should renal denervation be avoided in patients with isolated hypertension? Is the effect of renal denervation...

Truths and myths about renal denervation

What's new in hypertension treatment – An update for interventionists

23 May 2019 – From EuroPCR 2019

Consult this session to discover the updates in hypertension treatment: learn about new devices for hypertension management, how to apply the new hypertension guidelines in clinical practice, and more!

What's new in hypertension treatment – An update for interventionists

Unusual situations require smart techniques

23 May 2019 – From EuroPCR 2019

Consult this session to discover innovative techniques to cope with unusual situations, such as crossing of popliteal artery dissection by dual lumen microcatheter, stent extension outside the artery during stent deployment, blunt occlusive traumatic injury in the popliteal artery, and more!

Unusual situations require smart techniques

Myth busters – Truth or myth? Facts and data about renal denervation

22 May 2019 – From EuroPCR 2019

Consult this session to learn more about the fundamentals of radio-frequency ablation, the factors that may affect responders to renal denervation and the advancement of the renal denervation procedure.

Myth busters – Truth or myth? Facts and data about renal denervation